HC Wainwright & Co. Maintains Buy on Chimerix, Raises Price Target to $24

HC Wainwright & Co. analyst Edward White maintains Chimerix (NASDAQ:CMRX) with a Buy and raises the price target from $21 to $24.

HC Wainwright & Co. analyst Edward White maintains Chimerix (NASDAQ:CMRX) with a Buy and raises the price target from $21 to $24.

Total
0
Shares
Related Posts